Abstract
Caveolin-1 is the principal constituent protein of caveolae, which are specialised plasma membrane invaginations with diverse biological roles. Caveolin-1 is suggested to have tumour suppressive functions and CAV1 gene mutations have been reported in 20% of breast cancers. The aim of the present study was to evaluate the frequency of CAV1 mutations in a large cohort of optimally accrued breast cancers. Two independent series of breast cancer samples were analysed: 82 fresh-frozen grade 3 and 158 formalin-fixed paraffin-embedded invasive ductal carcinomas of no special type were consecutively accrued and subjected to microdissection of neoplastic epithelial cells prior to DNA extraction. Thirty-nine human breast cancer cell lines were also included in this study. The trans-membrane region of CAV1 and adjacent sequences, where mutations are reported to cluster, were amplified by PCR, followed by direct sequencing and mutational analysis. None of the reported CAV1 gene mutations, including CAV1 P132L, were identified in either clinical samples (95% CI: 0–1.5%) or human breast cancer cell lines analysed. One novel non-synonymous germline polymorphism was detected within a reported region of high mutational frequency. This study does not corroborate the reported frequent occurrence of CAV1 gene mutations, including CAV1 P132L, in primary human breast carcinomas. Our findings demonstrate that if CAV1 mutations do exist, their overall mutational frequency is substantially lower than positive reports have suggested. Taken together with other studies, which have also failed to identify CAV1 mutations, our data call into question the existence and biological and clinical relevance of CAV1 gene mutations in human breast cancer.
References
Lacroix-Triki M, Geyer FC, Reis-Filho JS (2010) Caveolin-1 P132L mutation in human cancers: 1 CAVeat to be voiced. J Mol Diagn 12(5):562–565. doi:10.2353/jmoldx.2010.100093
Sotgia F, Rui H, Bonuccelli G, Mercier I, Pestell RG, Lisanti MP (2006) Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers. Cancer Res 66(22):10647–10651. doi:10.1158/0008-5472.CAN-06-2805
Hayashi K, Matsuda S, Machida K, Yamamoto T, Fukuda Y, Nimura Y, Hayakawa T, Hamaguchi M (2001) Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res 61(6):2361–2364
Li T, Sotgia F, Vuolo MA, Li M, Yang WC, Pestell RG, Sparano JA, Lisanti MP (2006) Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status. Am J Pathol 168(6):1998–2013
Syeed N, Husain SA, Abdullah S, Sameer AS, Chowdri NA, Nanda MS, Siddiqi MA (2010) Caveolin-1 promotes mammary tumorigenesis: mutational profile of the Kashmiri population. Asian Pac J Cancer Prev 11(3):689–696
Koike S, Kodera Y, Nakao A, Iwata H, Yatabe Y (2010) Absence of the caveolin-1 P132L mutation in cancers of the breast and other organs. J Mol Diagn 12(5):712–717. doi:10.2353/jmoldx.2010.090180
Chen ST, Lin SY, Yeh KT, Kuo SJ, Chan WL, Chu YP, Chang JG (2004) Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers. Int J Mol Med 14(4):577–582
Geyer FC, Weigelt B, Natrajan R, Lambros MB, de Biase D, Vatcheva R, Savage K, Mackay A, Ashworth A, Reis-Filho JS (2010) Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. J Pathol 220(5):562–573. doi:10.1002/path.2675
Savage K, Lambros MB, Robertson D, Jones RL, Jones C, Mackay A, James M, Hornick JL, Pereira EM, Milanezi F, Fletcher CD, Schmitt FC, Ashworth A, Reis-Filho JS (2007) Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clin Cancer Res 13(1):90–101. doi:10.1158/1078-0432.CCR-06-1371
Williams C, Ponten F, Moberg C, Soderkvist P, Uhlen M, Ponten J, Sitbon G, Lundeberg J (1999) A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am J Pathol 155(5):1467–1471. doi:10.1016/S0002-9440(10)65461-2
Hurlstone AF, Reid G, Reeves JR, Fraser J, Strathdee G, Rahilly M, Parkinson EK, Black DM (1999) Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines. Oncogene 18(10):1881–1890. doi:10.1038/sj.onc.1202491
Sloan EK, Stanley KL, Anderson RL (2004) Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene 23(47):7893–7897. doi:10.1038/sj.onc.12080621208062
Acknowledgments
This study was funded by Breakthrough Breast Cancer. We acknowledge funding from the National Institute for Health Research to the Royal Marsden National Institute for Health Research Biomedical Research. JSR-F is a recipient of the 2010 Cancer Research UK Future Leaders Prize. NP is supported by a Royal College of Surgeons of England and Medical Research Council Clinical Research Training Fellowship.
Conflicts of interest
No potential conflicts of interest were disclosed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Patani, N., Lambros, M.B., Natrajan, R. et al. Non-existence of caveolin-1 gene mutations in human breast cancer. Breast Cancer Res Treat 131, 307–310 (2012). https://doi.org/10.1007/s10549-011-1761-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-011-1761-2